REPROCELL is pleased to announce that the first patient has been registered and the test article administered at Nagoya University in the Phase II clinical trial of the regenerative medicine product Stemchymal®.
Sign up to receive information from REPROCELL about our products, services, applications, promotions, and news (includes a weekly blog update email).
© 2020 REPROCELL Inc. All rights reserved.
REPROCELL USA Inc. Registered office REPROCELL USA Inc., 9000 Virginia Manor Road, Suite 207, Beltsville, 20705, USA, Registered in United States